Elanco Animal Health Inc (ELAN)
13.53
+0.06
(+0.45%)
USD |
NYSE |
May 03, 16:00
13.52
0.00 (0.00%)
After-Hours: 20:00
Elanco Animal Health Debt to Equity Ratio: 0.9278 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.9278 |
September 30, 2023 | 0.9633 |
June 30, 2023 | 0.817 |
March 31, 2023 | 0.8048 |
December 31, 2022 | 0.8007 |
September 30, 2022 | 0.8749 |
June 30, 2022 | 0.8492 |
March 31, 2022 | 0.8058 |
December 31, 2021 | 0.8416 |
September 30, 2021 | 0.8245 |
June 30, 2021 | 0.764 |
March 31, 2021 | 0.7695 |
December 31, 2020 | 0.7229 |
Date | Value |
---|---|
September 30, 2020 | 0.7359 |
June 30, 2020 | 0.3091 |
March 31, 2020 | 0.3095 |
December 31, 2019 | 0.4246 |
September 30, 2019 | 0.4301 |
June 30, 2019 | 0.4575 |
March 31, 2019 | 0.4745 |
December 31, 2018 | 0.4757 |
September 30, 2018 | 0.4825 |
June 30, 2018 | 0.00 |
March 31, 2018 | |
December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3091
Minimum
Jun 2020
0.9633
Maximum
Sep 2023
0.707
Average
0.8007
Median
Dec 2022
Debt to Equity Ratio Benchmarks
Merck & Co Inc | 0.9328 |
Catalent Inc | 1.358 |
NanoString Technologies Inc | -4.504 |
Cytokinetics Inc | -1.598 |
Geron Corp | 0.2399 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 14.36B |
Total Liabilities (Quarterly) | 8.139B |
Shareholders Equity (Quarterly) | 6.223B |
Current Ratio | 2.745 |
Net Debt Paydown Yield | 0.35% |